Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia [version 1; referees: 2 approved]
Fasting hypoglycemia is a known complication of mercaptopurine (6MP) maintenance therapy for acute lymphoblastic leukemia (ALL). It is associated with high levels of the methylated metabolite 6-methyl-mercaptopurine (6MMP). Symptoms of hypoglycemia include morning tremulousness, nausea and vomiting....
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
F1000 Research Ltd
2019-02-01
|
| סדרה: | F1000Research |
| גישה מקוונת: | https://f1000research.com/articles/8-176/v1 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|